Shibata M, Parfenova H, Zuckerman S L, Seyer J M, Krueger J M, Leffler C W
Department of Physiology and Biophysics, University of Tennessee, Memphis 38163 USA.
Am J Physiol. 1996 May;270(5 Pt 2):R1044-50. doi: 10.1152/ajpregu.1996.270.5.R1044.
Inflammatory cytokines may affect cerebral circulation under pathological conditions. Responses of cerebral pial arterioles to one such cytokine, interleukin (IL)-1 beta and its inhibitor [soluble IL-1 receptor (sIL-1R)] were examined in anesthetized newborn pigs using closed cranial windows. Levels of prostanoids and cyclic nucleotides in periarachnoid cerebral spinal fluid (CSF) were measured. To examine the structure-activity relationship of the parent IL-1 beta molecule, two IL-1 beta fragments with amino acid sequences of 187-204 [IL-1 beta-(187-204)] and 208-240 [IL-1 beta-(208-240)] were tested for their effects on pial arterioles. Diameter changes of pial arterioles were sequentially recorded every 5 min for 30 min after topical application of IL-1 peptides. CSF was sampled at the end of the 30 min. IL-1 beta dose dependently induced arteriolar dilation and increased prostaglandin E2 (PGE2), 6-keto-PGF1 alpha adenosine 3',5'-cyclic monophosphate (cAMP), and guanosine 3',5'-cyclic monophosphate (cGMP). Intravenous indomethacin blocked the IL-1 beta-induced vasodilation, the increased prostanoids, and the increased cAMP, but not the increased cGMP. Neither heat-inactivated IL-1 beta nor IL-1 beta vehicle affected arteriolar diameter or CSF levels of prostanoids. The sIL-1R blocked the IL-1 beta-induced vasodilation and the increased CSF prostanoids. IL-1 beta-(208-240) also induced pial arteriolar dilation; however, its vasodilatory potency was 1,000 times less than that of the whole IL-1 beta molecule. IL-1 beta-(187-204) did not induce pial arteriolar dilation even when its dose was increased to the level of IL-1 beta-(208-240). These results suggest that IL-1 beta, through the activation of membrane-bound IL-1 beta receptors, induces pial arteriolar dilation via mechanisms that involve prostanoids and cyclic nucleotides. The results also indicate that the 208-240 amino acid sequence of IL-1 beta has a sequence-specific physiological function.
在病理条件下,炎性细胞因子可能会影响脑循环。我们使用封闭的颅骨视窗,在麻醉的新生猪中研究了软脑膜小动脉对其中一种细胞因子白细胞介素(IL)-1β及其抑制剂[可溶性IL-1受体(sIL-1R)]的反应。测量了蛛网膜下腔脑脊液(CSF)中前列腺素和环核苷酸的水平。为了研究亲本IL-1β分子的构效关系,测试了两种氨基酸序列为187 - 204[IL-1β-(187 - 204)]和208 - 240[IL-1β-(208 - 240)]的IL-1β片段对软脑膜小动脉的影响。在局部应用IL-1肽后,每隔5分钟连续记录软脑膜小动脉直径变化30分钟。在30分钟结束时采集CSF样本。IL-1β剂量依赖性地诱导小动脉扩张,并增加前列腺素E2(PGE2)、6-酮-前列腺素F1α、腺苷3',5'-环磷酸(cAMP)和鸟苷3',5'-环磷酸(cGMP)。静脉注射吲哚美辛可阻断IL-1β诱导的血管舒张、前列腺素增加和cAMP增加,但不能阻断cGMP增加。热灭活的IL-1β和IL-1β载体均不影响小动脉直径或CSF中前列腺素水平。sIL-1R可阻断IL-1β诱导的血管舒张和CSF中前列腺素增加。IL-1β-(208 - 240)也可诱导软脑膜小动脉扩张;然而,其血管舒张效力比整个IL-1β分子低1000倍。即使将IL-1β-(187 - 204)的剂量增加到IL-1β-(208 - 240)的水平,它也不会诱导软脑膜小动脉扩张。这些结果表明,IL-1β通过激活膜结合的IL-1β受体,经由涉及前列腺素和环核苷酸的机制诱导软脑膜小动脉扩张。结果还表明,IL-1β的208 - 240氨基酸序列具有序列特异性生理功能。